Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility

Nature Genetics

Volumn 37, Issue 4, 2005, Pages 365-372

  Wang, Xiaosong ^a   Ria, Massimiliano ^b   Kelmenson, Peter M ^a   Eriksson, Per ^b   Higgins, David C ^a   Samnegård, Ann ^b   Petros, Christina ^a   Rollins, Jarod ^a   Bennet, Anna M ^c   Wiman, Björn ^d   De Faire, Ulf ^c,e   Wennberg, Charlotte ^f   Olsson, Per G ^f   Ishii, Naoto ^g   Sugamura, Kazuo ^g   Hamsten, Anders ^b   Forsman Semb, Kristina ^f   Lagercrantz, Jacob ^b   Paigen, Beverly ^a  

^a JACKSON LABORATORY   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c Institute for Environmental Medicine   (United States)

^d Div Clin Chem and Blood Coagul

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^f ASTRAZENECA R AND D   (Sweden)

^g TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD134 ANTIGEN; TUMOR NECROSIS FACTOR DERIVATIVE;

ARTICLE; ATHEROSCLEROSIS; CHROMOSOME 1; CONTROLLED STUDY; DNA POLYMORPHISM; GENE FREQUENCY; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENETIC SUSCEPTIBILITY; HEART INFARCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; STATISTICAL SIGNIFICANCE;

AGED; ANIMALS; ANTIGENS, CD27; AORTA; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; CASE-CONTROL STUDIES; CHOLESTEROL, DIETARY; CROSSES, GENETIC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, KNOCKOUT; MIDDLE AGED; OX40 LIGAND; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT LOCI; TUMOR NECROSIS FACTORS;

EID: 20144386616     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng1524     Document Type: Article

References (46)

1. Paigen, B., Morrow, A., Brandon, C., Mitchell, D. & Holmes, P. Variation in susceptibility to atherosclerosis among inbred strains of mice. Atherosclerosis 57, 65-73 (1985).
2. Paigen, B. et al. Ath-1, a gene determining atherosclerosis susceptibility and high density lipoprotein levels in mice. Proc. Natl. Acad. Sci. USA 84, 3763-3767 (1987).
3. Paigen, B., Albee, D., Holmes, P.A. & Mitchell, D. Genetic analysis of murine strains C57BL/6J and C3H/HeJ to confirm the map position of Ath-1, a gene determining atherosclerosis susceptibility. Biochem. Genet. 25, 501-511 (1987).
4. Phelan, S.A., Beier, D.R., Higgins, D.C. & Paigen, B. Confirmation and high resolution mapping of an atherosclerosis susceptibility gene in mice on Chromosome 1. Mamm. Genome 13, 548-553 (2002).
5. Wang, X. et al. Mice with targeted mutation of peroxiredoxin 6 develop normally but are susceptible to oxidative stress. J. Biol. Chem. 278, 25179-25190 (2003).
6. Phelan, S.A., Wang, X., Wallbrandt, P., Forsman-Semb, K. & Paigen, B. Overexpression of Prdx6 reduces H202 but does not prevent diet-induced atherosclerosis in the aortic root. Free Radic. Biol. Med. 35, 1110-1120 (2003).
7. Wang, X. et al. Peroxiredoxin 6 deficiency and atherosclerosis susceptibility in mice: significance of genetic background for assessing atherosclerosis. Atherosclerosis 177, 61-70 (2004).
8. Geng, Y.J. Biologic effect and molecular regulation of vascular apoptosis in atherosclerosis. Curr. Atheroscler. Rep. 3, 234-242 (2001).
9. Weinberg, A.D. OX40: targeted immunotherapy-implications for tempering autoimmunity and enhancing vaccines. Trends Immunol. 23, 102-109 (2002).
10. Hansson, G.K., Libby, P., Schonbeck, U. & Yan, Z.Q. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ. Res. 91, 281-291 (2002).
11. Shi, W. et al. Genetic backgrounds but not sizes of atherosclerotic lesions determine medial destruction in the aortic root of apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 23, 1901-1906 (2003).
12. Mehrabian, M. et al. Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice. Circ. Res. 91, 120-126 (2002).
13. Emeson, E.E., Shen, M.L., Bell, C.G. & Qureshi, A. Inhibition of atherosclerosis in CD4 T-cell-ablated and nude (nu/nu) C57BL/6 hyperlipidemic mice. Am. J. Pathol. 149, 675-685 (1996).
14. Nakai, Y. et al. Natural killer T cells accelerate atherogenesis in mice. Blood 104, 2051-2059 (2004).
15. Major, A.S., Fazio, S. & Linton, M.F. B-lymphocyte deficiency increases atherosclerosis in LDL receptor-null mice. Arterioscler. Thromb. Vasc. Biol. 22, 1892-1898 (2002).
16. Caligiuri, G., Nicoletti, A., Poirier, B. & Hansson, G.K. Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. J. Clin. Invest. 109, 745-753 (2002).
17. Reardon, C.A. et al. Effect of immune deficiency on lipoproteins and atherosclerosis in male apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 21, 1011-1016 (2001).
18. Song, L., Leung, C. & Schindler, C. Lymphocytes are important in early atherosclerosis. J. Clin. Invest. 108, 251-259 (2001).
19. Dansky, H.M., Charlton, S.A., Harper, M.M. & Smith, J.D. T and B lymphocytes playa minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. Proc. Natl. Acad. Sci. USA 94, 4642-4646 (1997).
20. Geng, Y.J. & Libby, P. Progression of atheroma: a struggle between death and procreation. Arterioscler. Thromb. Vasc. Biol. 22, 1370-1380 (2002).
21. Yang, J. et al. Endothelial overexpression of Fas ligand decreases atherosclerosis in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 24, 1466-1473 (2004).
22. Aprahamian, T. et al. Impaired clearance of apoptotic cells promotes synergy between atherogenesis and autoimmune disease. J. Exp. Med. 199, 1121-1131 (2004).
23. Schneider, D.B. et al. Expression of Fas ligand in arteries of hypercholesterolemic rabbits accelerates atherosclerotic lesion formation. Arterioscler. Thromb. Vasc. Biol. 20, 298-308 (2000).
24. Kotani, A., Hori, T., Matsumura, Y. & Uchiyama, T. Signaling of gp34 (OX40 ligand) induces vascular endothelial cells to produce a CC chemokine RANTES/CCL5. Immunol. Lett. 84, 1-7 (2002).
25. Kawai, T. et al. Selective diapedesis of Th1 cells induced by endothelial cell RANTES. J. Immunol. 163, 3269-3278 (1999).
26. Welch, C.L. et al. Localization of atherosclerosis susceptibility loci to chromosomes 4 and 6 using the Ldlr knockout mouse model. Proc. Natl. Acad. Sci. USA 98, 7946-7951 (2001).
27. Hauser, E.R. et al. A genomewide scan for early-onset coronary artery disease in 438 families: the GENECARD Study. Am. J. Hum. Genet. 75, 436-447 (2004).
28. Wang, Q. et al. Premature myocardial infarction novel susceptibility locus on chromosome 1p34-36 identified by genomewide linkage analysis. Am. J. Hum. Genet. 74, 262-271 (2004).
29. Abiola, O. et al. The nature and identification of quantitative trait loci: a community's view. Nat. Rev. Genet. 4, 911-916 (2003).
30. Stary, H.C. et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 92, 1355-1374 (1995).
31. Edfeldt, K. et al. Association of hypo-responsive toll-like receptor 4 variants with risk of myocardial infarction. Eur. Heart J. 25, 1447-1453 (2004).
32. Paigen, B., Holmes, P.A., Mitchell, D. & Albee, D. Comparison of atherosclerotic lesions and HDL-lipid levels in male, female, and testosterone-treated female mice from strains C57BL/6, BALB/c, and C3H. Atherosclerosis 64, 215-221 (1987).
33. Sugamura, K., Ishii, N. & Weinberg, A.D. Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40. Nat. Rev. Immunol. 4, 420-431 (2004).
34. Murata, K. et al. Impairment of antigen-presenting cell function in mice lacking expression of OX40 ligand. J. Exp. Med. 191, 365-374 (2000).
35. Nishina, P.M., Verstuyft, J. & Paigen, B. Synthetic low and high fat diets for the study of atherosclerosis in the mouse. J. Lipid Res. 31, 859-869 (1990).
36. Paigen, B. et al. Ath-1, a gene determining atherosclerosis susceptibility and high density lipoprotein levels in mice. Proc. Natl. Acad. Sci. USA 84, 3763-3767 (1987).
37. Paigen, B., Mitchell, D., Holmes, P.A. & Albee, D. Genetic analysis of strains C57BL/6J and BALB/cJ for Ath-1, a gene determining atherosclerosis susceptibility in mice. Biochem. Genet. 25, 881-892 (1987).
38. Paigen, B., Albee, D., Holmes, P.A. & Mitchell, D. Genetic analysis of murine strains C57BL/6J and C3H/HeJ to confirm the map position of Ath-1, a gene determining atherosclerosis susceptibility. Biochem. Genet. 25, 501-511 (1987).
39. Paigen, B., Morrow, A., Holmes, P.A., Mitchell, D. & Williams, R.A. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis 68, 231-240 (1987).
40. Wang, X. et al. Using advanced intercross lines for high-resolution mapping of HDL cholesterol quantitative trait loci. Genome. Res. 13, 1654-1664 (2003).
41. Eriksson, P. et al. Human evidence that the cystatin C gene is implicated in focal progression of coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 24, 551-557 (2004).
42. Reuterwall, C. et al. Higher relative, but lower absolute risks of myocardial infarction in women than in men: analysis of some major risk factors in the SHEEP study. The SHEEP Study Group. J. Intern. Med. 246, 161-174 (1999).
43. Boquist, S. et al. Alimentary lipemia, postprandial triglyceride-rich lipoproteins, and common carotid intima-media thickness in healthy, middle-aged men. Circulation 100, 723-728 (1999).
44. Austen, W.G. et al. A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 51, 5-40 (1975).
45. Ronaghi, M., Uhlen, M. & Nyren, P. A sequencing method based on real-time pyrophosphate. Science 281, 363-365 (1998).
46. Niu, T., Qin, Z.S., Xu, X. & Liu, J.S. Bayesian haplotype inference for multiple linked single-nucleotide polymorphisms. Am. J. Hum. Genet. 70, 157-169 (2002).